Log in

NASDAQ:MDRX - Allscripts Healthcare Solutions Stock Price, Forecast & News

$8.98
-0.18 (-1.97 %)
(As of 01/26/2020 05:54 AM ET)
Today's Range
$8.86
Now: $8.98
$9.15
50-Day Range
$8.98
MA: $9.68
$10.06
52-Week Range
$8.75
Now: $8.98
$12.40
Volume2.54 million shs
Average Volume2.09 million shs
Market Capitalization$1.46 billion
P/E Ratio7.68
Dividend YieldN/A
Beta1.38
Allscripts Healthcare Solutions, Inc provides information technology solutions and services to healthcare organizations in the United States, Canada, and internationally. It offers electronic health records (EHR), connectivity, private cloud hosting, outsourcing, analytics, patient engagement, clinical decision support, and population health management solutions. Read More…

Industry, Sector and Symbol

Industry Computer integrated systems design
Sub-IndustryHealth Care Technology
SectorMedical
Current SymbolNASDAQ:MDRX
CUSIP01988P10
Phone800-334-8534

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$1.75 billion
Cash Flow$1.70 per share
Book Value$9.05 per share

Profitability

Net Income$412.33 million

Miscellaneous

Employees9,500
Market Cap$1.46 billion
Next Earnings Date2/20/2020 (Estimated)
OptionableOptionable

Receive MDRX News and Ratings via Email

Sign-up to receive the latest news and ratings for MDRX and its competitors with MarketBeat's FREE daily newsletter.


Allscripts Healthcare Solutions (NASDAQ:MDRX) Frequently Asked Questions

What is Allscripts Healthcare Solutions' stock symbol?

Allscripts Healthcare Solutions trades on the NASDAQ under the ticker symbol "MDRX."

How will Allscripts Healthcare Solutions' stock buyback program work?

Allscripts Healthcare Solutions announced that its board has authorized a share repurchase program on Thursday, August 2nd 2018, which permits the company to repurchase $250,000,000.00 in shares, according to EventVestor. This repurchase authorization permits the company to purchase up to 11.3% of its stock through open market purchases. Stock repurchase programs are typically a sign that the company's board of directors believes its stock is undervalued.

How were Allscripts Healthcare Solutions' earnings last quarter?

Allscripts Healthcare Solutions Inc (NASDAQ:MDRX) announced its quarterly earnings data on Monday, November, 4th. The software maker reported $0.17 earnings per share (EPS) for the quarter, hitting the Zacks' consensus estimate of $0.17. The software maker earned $445 million during the quarter, compared to analysts' expectations of $450.04 million. Allscripts Healthcare Solutions had a net margin of 12.00% and a return on equity of 5.98%. The business's revenue was up 2.9% on a year-over-year basis. During the same period in the prior year, the firm earned $0.18 earnings per share. View Allscripts Healthcare Solutions' Earnings History.

When is Allscripts Healthcare Solutions' next earnings date?

Allscripts Healthcare Solutions is scheduled to release their next quarterly earnings announcement on Thursday, February 20th 2020. View Earnings Estimates for Allscripts Healthcare Solutions.

What guidance has Allscripts Healthcare Solutions issued on next quarter's earnings?

Allscripts Healthcare Solutions issued an update on its fourth quarter 2019 Pre-Market earnings guidance on Tuesday, January, 14th. The company provided EPS guidance of for the period. The company issued revenue guidance of $450-455 million, compared to the consensus revenue estimate of $463.08 million.

What price target have analysts set for MDRX?

7 equities research analysts have issued 1 year price objectives for Allscripts Healthcare Solutions' stock. Their forecasts range from $10.00 to $13.00. On average, they expect Allscripts Healthcare Solutions' share price to reach $11.71 in the next year. This suggests a possible upside of 30.4% from the stock's current price. View Analyst Price Targets for Allscripts Healthcare Solutions.

What is the consensus analysts' recommendation for Allscripts Healthcare Solutions?

7 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Allscripts Healthcare Solutions in the last year. There are currently 5 hold ratings and 2 buy ratings for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for Allscripts Healthcare Solutions.

What are Wall Street analysts saying about Allscripts Healthcare Solutions stock?

Here are some recent quotes from research analysts about Allscripts Healthcare Solutions stock:
  • 1. According to Zacks Investment Research, "Allscripts ended the third quarter on a mixed note. The company continues to gain from the core Client Services unit, which displayed an improved performance in the quarter. Significant growth in third-quarter bookings also buoys optimism. The company continues to maintain momentum in its Provider business on the back of key client wins across solution set. The company is confident about its near and long-term outlook as it anticipates to benefit from a number of differentiated growth opportunities in both Provider and Veradigm businesses. However, the company witnessed a contraction in both gross and operating margins in the third quarter. It is also exposed to integration risks. Intense competition in the niche space is an added concern. Over the past year, Allscripts has underperformed its industry." (12/3/2019)
  • 2. Cantor Fitzgerald analysts commented, ". We reiterate our Neutral rating on MDRX shares and maintain our price target at $10, After the market close on Thursday, May 2, MDRX reported 1Q19 results, with revenue slightly below our estimate. 1Q19 bookings increased 9% y/y. MDRX reiterated its 2019 guidance for non-GAAP EPS and bookings. The company continues its policy of not providing full year revenue guidance, but provided 2Q19 revenue guidance, which was below our estimate but in line with FactSet consensus. We note the company had previously provided a modest three-year CAGR outlook." (5/2/2019)

Has Allscripts Healthcare Solutions been receiving favorable news coverage?

News articles about MDRX stock have trended extremely negative this week, InfoTrie Sentiment reports. The research firm scores the sentiment of news coverage by reviewing more than six thousand blog and news sources in real time. The firm ranks coverage of publicly-traded companies on a scale of -5 to 5, with scores closest to five being the most favorable. Allscripts Healthcare Solutions earned a daily sentiment score of -4.5 on InfoTrie's scale. They also assigned headlines about the software maker a news buzz of 10.0 out of 10, indicating that recent news coverage is extremely likely to have an effect on the company's share price in the immediate future. View News Stories for Allscripts Healthcare Solutions.

Are investors shorting Allscripts Healthcare Solutions?

Allscripts Healthcare Solutions saw a increase in short interest in December. As of December 13th, there was short interest totalling 26,550,000 shares, an increase of 16.8% from the November 28th total of 22,730,000 shares. Based on an average daily trading volume, of 1,810,000 shares, the days-to-cover ratio is currently 14.7 days. Approximately 16.7% of the shares of the company are sold short. View Allscripts Healthcare Solutions' Current Options Chain.

Who are some of Allscripts Healthcare Solutions' key competitors?

Some companies that are related to Allscripts Healthcare Solutions include Cerner (CERN), Omnicell (OMCL), HMS (HMSY), Cortexyme (CRTX), HealthStream (HSTM), Vocera Communications (VCRA) and Computer Programs & Systems (CPSI).

What other stocks do shareholders of Allscripts Healthcare Solutions own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Allscripts Healthcare Solutions investors own include Advanced Micro Devices (AMD), Netflix (NFLX), Walgreens Boots Alliance (WBA), Starbucks (SBUX), Activision Blizzard (ATVI), Nuance Communications (NUAN), AK Steel (AKS), Ford Motor (F), Oasis Petroleum (OAS) and American Airlines Group (AAL).

Who are Allscripts Healthcare Solutions' key executives?

Allscripts Healthcare Solutions' management team includes the folowing people:
  • Mr. Paul M. Black, CEO & Director (Age 61)
  • Mr. Richard J. Poulton, Pres (Age 54)
  • Mr. Dennis M. Olis, Chief Financial Officer (Age 56)
  • Mr. Brian P. Farley, Exec. VP, Gen. Counsel, Corp. Sec. & Chief Admin. Officer (Age 49)
  • Ms. Lisa Khorey, Exec. VP & Chief Client Delivery Officer (Age 52)

Who are Allscripts Healthcare Solutions' major shareholders?

Allscripts Healthcare Solutions' stock is owned by a variety of of retail and institutional investors. Top institutional investors include Peregrine Capital Management LLC (0.84%), Smith Graham & Co. Investment Advisors LP (0.59%), Campbell & CO Investment Adviser LLC (0.02%), State of Alaska Department of Revenue (0.02%), Eqis Capital Management Inc. (0.01%) and Janney Montgomery Scott LLC (0.01%). Company insiders that own Allscripts Healthcare Solutions stock include Brian Farley, Dennis Olis, Mara G Aspinall, Michael Klayko, Paul Black, Richard J Poulton and Yancey L Spruill. View Institutional Ownership Trends for Allscripts Healthcare Solutions.

Which institutional investors are selling Allscripts Healthcare Solutions stock?

MDRX stock was sold by a variety of institutional investors in the last quarter, including Peregrine Capital Management LLC, Janney Montgomery Scott LLC and State of Alaska Department of Revenue. View Insider Buying and Selling for Allscripts Healthcare Solutions.

Which institutional investors are buying Allscripts Healthcare Solutions stock?

MDRX stock was bought by a variety of institutional investors in the last quarter, including Smith Graham & Co. Investment Advisors LP, Campbell & CO Investment Adviser LLC, Eqis Capital Management Inc. and Carroll Financial Associates Inc.. Company insiders that have bought Allscripts Healthcare Solutions stock in the last two years include Mara G Aspinall, Michael Klayko, Paul Black and Yancey L Spruill. View Insider Buying and Selling for Allscripts Healthcare Solutions.

How do I buy shares of Allscripts Healthcare Solutions?

Shares of MDRX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is Allscripts Healthcare Solutions' stock price today?

One share of MDRX stock can currently be purchased for approximately $8.98.

How big of a company is Allscripts Healthcare Solutions?

Allscripts Healthcare Solutions has a market capitalization of $1.46 billion and generates $1.75 billion in revenue each year. The software maker earns $412.33 million in net income (profit) each year or $0.55 on an earnings per share basis. Allscripts Healthcare Solutions employs 9,500 workers across the globe.View Additional Information About Allscripts Healthcare Solutions.

What is Allscripts Healthcare Solutions' official website?

The official website for Allscripts Healthcare Solutions is http://www.allscripts.com/.

How can I contact Allscripts Healthcare Solutions?

Allscripts Healthcare Solutions' mailing address is 222 MERCHANDISE MART PLAZA SUITE 2024, CHICAGO IL, 60654. The software maker can be reached via phone at 800-334-8534 or via email at [email protected]


MarketBeat Community Rating for Allscripts Healthcare Solutions (NASDAQ MDRX)

Community Ranking:  2.4 out of 5 (star star)
Outperform Votes:  597 (Vote Outperform)
Underperform Votes:  641 (Vote Underperform)
Total Votes:  1,238
MarketBeat's community ratings are surveys of what our community members think about Allscripts Healthcare Solutions and other stocks. Vote "Outperform" if you believe MDRX will outperform the S&P 500 over the long term. Vote "Underperform" if you believe MDRX will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 1/26/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel